Business
Annual Report & Notice of AGM
Annual Report & Notice of AGM.
About this update from Immupharma Plc
[{"type":"text","content":"\n \nRNS Number : 3430H Immupharma PLC 07 June 2017 \n\n \n\n\n\n\n\n\n\n 7 June 2017\n\n\n\n\n \nImmuPharma PLC\n(\"ImmuPharma\" or the \"Company\")\n \n \nANNUAL REPORT AND ACCOUNTS POSTED TO SHAREHOLDERS\n\nNOTICE OF ANNUAL GENERAL MEETING ON 30 JUNE 2017 @ 10.30 AM\n \nINVESTOR PRESENTATION TO FOLLOW AT 11.30 AM\n \nVENUE: SKY LIGHT CITY, 50 BASINGHALL STREET, LONDON, EC2\n \nImmuPharma PLC (LSE:IMM), (\"ImmuPharma\" or the \"Company\"), the specialist drug discovery and development company confirms that today the Annual Report and Accounts for the year ended 31 December 2016 has today been posted to shareholders.\nThis report includes the 'Annual Report of the Annual General Meeting' ('AGM') as well as the 'Notice of the 2017 AGM', which will be available later today, in electronic form, for download on the Company's website www.immupharma.org.\nImmuPharma's AGM will be held on Friday 30 June at 10:30am at Sky Light City Tower, 50 Basinghall Street, EC2V 5DE.\nInvestor Meeting @ 11.30am on 30 June 2017 \n \nImmuPharma has confirmed that it will be hosting an Investor Presentation and luncheon immediately following the Company's Annual General Meeting at 11.30am. Please contact Lisa Baderoon at [email protected] if you would like to attend this event.\n \n\n\n\n\n-Ends-\n \n \n \n\n\n\n\nFor further information please contact:\n \n\n\n\n\nImmuPharma plc (www.immupharma.org)\n\n\n+ 44 (0) 20 7152 4080\n\n\n\n\nTim McCarthy, Chairman\n\n\n\n\n\n\n\nLisa Baderoon, Head of Investor Relations\nTwitter: @immupharma\n \n\n\n+ 44 (0) 7721 413496\n \n \n\n\n\n\n\n\n\n\n\n\n\n\n \nNorthland Capital Partners Limited (Joint Broker)\nPatrick Claridge, David Hignell, Corporate Finance\nRob Rees, Corporate Broking\n \n \n\n\n \n+44 (0)20 3861 6625\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\nThis information is provided by RNSThe company news service from the London Stock Exchange END&nb...